EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Dorzolamide Chlorhydrate versus Acetazolamide in the Management of Chronic Macular Edema in Patients with Retinitis Pigmentosa: Description of Three Case Reports

Elena Pacella, Loredana Arrico, Valentina Santamaria, Paolo Turchetti, Maria Rosaria Carbotti, Giuseppe La Torre, Fernanda Pacella

Ophthalmology and Eye Diseases · 2014

DOI: 10.4137/oed.s13617 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Ophthalmology and Eye Diseases, 2014. Verfasst von Elena Pacella und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sense Organs, Faculty of Medicine and Dentistry, Sapienza University of Rome, Italy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To assess the efficacy of topical dorzolamide for treating cystoid macular edema in patients with retinitis pigmentosa and minimize the secondary effects of maintenance therapy in patients with retinitis pigmentosa (RP) who present with chronic microcystic macular edema.

Methods

To replace acetazolamide systemic treatment, with a topical treatment using 2% dorzolamide in three patients. The methods performed were OCT scan with a Spectralis HRA-OCT, for the measurement of macular thickness and morphology; best corrected visual acuity was assessed using Early Treatment Diabetic Retinopathy Study (ETDRS), was assessed slit-lamp biomicroscopy, ocular tonometry, fundus biomiocrosopy, and color fundus photography. This therapeutic protocol has been applied and described in three patients.

Results

In all three tested patients, following the administration of dorzolamide in eye drop, we observed a remarkable decrease in macular edema, almost comparable to that obtained with acetazolamide per os.

Conclusion

The study confirms the anti-edematogenic effect of topical dorzolamide in RP with recurring macular cysts, as this can have a favorable response with topical dorzolamide. In all the three examined patients, the instillation of topical dorzolamide caused a remarkable reduction in their macular edema, as highlighted on OCT.

Schlagwörter

Stichwörter der Autor:innen

acetazolamidecystoid macular edemadorzolamideretinitis pigmentosa

Autor:innen und Institutionen

  • Department of Sense Organs, Faculty of Medicine and Dentistry, Sapienza University of Rome, Italy.
  • National Institute for Health, Migration and Poverty (INMP/NIHMP), Rome, Italy.
  • Department of Public Health and Infectious Diseases, Faculty of Farmacy and Medicine, Sapienza University of Rome, Italy.

Zitieren

APA

Pacella, E., Arrico, L., Santamaria, V., Turchetti, P., Carbotti, M. R., La Torre, G., & Pacella, F. (2014). Dorzolamide Chlorhydrate versus Acetazolamide in the Management of Chronic Macular Edema in Patients with Retinitis Pigmentosa: Description of Three Case Reports. Ophthalmology and Eye Diseases. https://doi.org/10.4137/oed.s13617

Vancouver

Pacella E, Arrico L, Santamaria V, Turchetti P, Carbotti MR, La Torre G, et al. Dorzolamide Chlorhydrate versus Acetazolamide in the Management of Chronic Macular Edema in Patients with Retinitis Pigmentosa: Description of Three Case Reports. Ophthalmology and Eye Diseases. 2014. doi:10.4137/oed.s13617

BibTeX
@article{Pacella2014,
  author = {Pacella, Elena and Arrico, Loredana and Santamaria, Valentina and Turchetti, Paolo and Carbotti, Maria Rosaria and La Torre, Giuseppe and Pacella, Fernanda},
  title = {Dorzolamide Chlorhydrate versus Acetazolamide in the Management of Chronic Macular Edema in Patients with Retinitis Pigmentosa: Description of Three Case Reports},
  journal = {Ophthalmology and Eye Diseases},
  year = {2014},
  doi = {10.4137/oed.s13617}
}
Kostenlos starten →